Kewaunee Scientific Corporation
KEQU · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $120 | $158 | $90 | $185 |
| - Cash | $13 | $19 | $15 | $9 |
| + Debt | $18 | $18 | $50 | $56 |
| Enterprise Value | $125 | $157 | $126 | $231 |
| Revenue | $70 | $71 | $77 | $67 |
| % Growth | -1.4% | -7.8% | 14.9% | – |
| Gross Profit | $20 | $21 | $24 | $18 |
| % Margin | 28.1% | 29.4% | 31.2% | 27.4% |
| EBITDA | $6 | $7 | $10 | $4 |
| % Margin | 8.7% | 9.2% | 12.8% | 5.9% |
| Net Income | $2 | $3 | $5 | $1 |
| % Margin | 3.5% | 4.3% | 6.3% | 2% |
| EPS Diluted | 0.82 | 1.04 | 1.63 | 0.45 |
| % Growth | -21.2% | -36.2% | 262.2% | – |
| Operating Cash Flow | -$4 | $6 | $9 | -$2 |
| Capital Expenditures | -$2 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$6 | $5 | $9 | -$3 |